BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 25808031)

  • 1. Erratum to: A Stable Human-Cell System Overexpressing Cystic Fibrosis Transmembrane Conductance Regulator Recombinant Protein at the Cell Surface.
    Hildebrandt E; Ding H; Mulky A; Dai Q; Aleksandrov AA; Bajrami B; Diego PA; Wu X; Ray M; Naren AP; Riordan JR; Yao X; DeLucas LJ; Urbatsch IL; Kappes JC
    Mol Biotechnol; 2015 May; 57(5):406. PubMed ID: 25808031
    [No Abstract]   [Full Text] [Related]  

  • 2. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
    Namkung W; Kim KH; Lee MG
    Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis transmembrane conductance regulator protein expression in the male excretory duct system during development.
    Marcorelles P; Gillet D; Friocourt G; Ledé F; Samaison L; Huguen G; Ferec C
    Hum Pathol; 2012 Mar; 43(3):390-7. PubMed ID: 21840567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis transmembrane conductance regulator in human and mouse red blood cell membranes and its interaction with ecto-apyrase.
    Sterling KM; Shah S; Kim RJ; Johnston NI; Salikhova AY; Abraham EH
    J Cell Biochem; 2004 Apr; 91(6):1174-82. PubMed ID: 15048872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
    Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
    Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
    Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
    J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene.
    Tabcharani JA; Chang XB; Riordan JR; Hanrahan JW
    Nature; 1991 Aug; 352(6336):628-31. PubMed ID: 1714039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-α-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure.
    Meissner A; Yang J; Kroetsch JT; Sauvé M; Dax H; Momen A; Noyan-Ashraf MH; Heximer S; Husain M; Lidington D; Bolz SS
    Circulation; 2012 Jun; 125(22):2739-50. PubMed ID: 22534621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mGluR1 interacts with cystic fibrosis transmembrane conductance regulator and modulates the secretion of IL-10 in cystic fibrosis peripheral lymphocytes.
    Shanshiashvili LV; Dabrundashvili N; Natsvlishvili N; Kvaratskhelia E; Zhuravliova E; Barbakadze T; Koriauli S; Maisuradze E; Topuria T; Mikeladze DG
    Mol Immunol; 2012 Jul; 51(3-4):310-5. PubMed ID: 22520513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium.
    Puchelle E; Gaillard D; Ploton D; Hinnrasky J; Fuchey C; Boutterin MC; Jacquot J; Dreyer D; Pavirani A; Dalemans W
    Am J Respir Cell Mol Biol; 1992 Nov; 7(5):485-91. PubMed ID: 1384582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel.
    Berger HA; Anderson MP; Gregory RJ; Thompson S; Howard PW; Maurer RA; Mulligan R; Smith AE; Welsh MJ
    J Clin Invest; 1991 Oct; 88(4):1422-31. PubMed ID: 1717515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.
    Mall M; Bleich M; Greger R; Schreiber R; Kunzelmann K
    J Clin Invest; 1998 Jul; 102(1):15-21. PubMed ID: 9649552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic and single-particle analyses of native- and nucleotide-bound forms of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
    Awayn NH; Rosenberg MF; Kamis AB; Aleksandrov LA; Riordan JR; Ford RC
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):996-9. PubMed ID: 16246030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for cystic fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. A phase I study.
    Hum Gene Ther; 1994 Aug; 5(8):1019-57. PubMed ID: 7948139
    [No Abstract]   [Full Text] [Related]  

  • 17. Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia.
    Denning GM; Ostedgaard LS; Cheng SH; Smith AE; Welsh MJ
    J Clin Invest; 1992 Jan; 89(1):339-49. PubMed ID: 1370301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
    Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
    Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.
    Sirninger J; Muller C; Braag S; Tang Q; Yue H; Detrisac C; Ferkol T; Guggino WB; Flotte TR
    Hum Gene Ther; 2004 Sep; 15(9):832-41. PubMed ID: 15353038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.